<![CDATA[Genmab — Oktober 2017]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/topic/451511/genmab-oktober-2017RSS for NodeSun, 14 Jun 2026 08:29:05 GMTSun, 01 Oct 2017 03:35:40 GMT60<![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 20:41:37 GMT]]>
ClinicalTrials.gov

favicon

(clinicaltrials.gov)

]]>https://dev.proinvestor.com/forum/post/10160684https://dev.proinvestor.com/forum/post/10160684Tue, 31 Oct 2017 20:41:37 GMT<![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 20:36:28 GMT]]>Isatuximab (SAR) parate til firstline ph3. Study data 2022. Tre år efter sc-dara er i luften.

]]>https://dev.proinvestor.com/forum/post/10160683https://dev.proinvestor.com/forum/post/10160683Tue, 31 Oct 2017 20:36:28 GMT<![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 20:16:05 GMT]]>
  • og Solsens forståelige vidnesbyrd!:-)
    • ]]>    https://dev.proinvestor.com/forum/post/10160682https://dev.proinvestor.com/forum/post/10160682Tue, 31 Oct 2017 20:16:05 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 19:58:03 GMT]]>https://www.readbyqxmd.com/read/28840598/therapeutic-monoclonal-antibodies-in-combination-with-pomalidomide-can-overcome-refractoriness-to-both-agents-in-multiple-myeloma-a-case-based-approach Interessant iagtagelse

    ]]>    https://dev.proinvestor.com/forum/post/10160685https://dev.proinvestor.com/forum/post/10160685Tue, 31 Oct 2017 19:58:03 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 19:26:22 GMT]]>https://m.youtube.com/watch?v=po_QS2c-oz8 Sidstnævntes forståelige vidnesbyrd.

    ]]>    https://dev.proinvestor.com/forum/post/10160680https://dev.proinvestor.com/forum/post/10160680Tue, 31 Oct 2017 19:26:22 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 19:16:54 GMT]]>...Limo Chen, Torben Plesner etc 😉

    ]]>    https://dev.proinvestor.com/forum/post/10160679https://dev.proinvestor.com/forum/post/10160679Tue, 31 Oct 2017 19:16:54 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 19:14:56 GMT]]>Jo i følge Winkel.

    ]]>    https://dev.proinvestor.com/forum/post/10160678https://dev.proinvestor.com/forum/post/10160678Tue, 31 Oct 2017 19:14:56 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 19:08:36 GMT]]>og det er vel på nuværende tidspunkt ikke de store indikationer på?

    ]]>    https://dev.proinvestor.com/forum/post/10160681https://dev.proinvestor.com/forum/post/10160681Tue, 31 Oct 2017 19:08:36 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 19:07:47 GMT]]>Da jeg er ung og ikke har så mange forpligtelser, er jeg ikke afhængig af de penge, jeg har investeret, hvorfor jeg har en høj risikovillighed (ikke så høj, at vi snakker penny-stocks). Derfor er jeg begyndt at tænke, om Genmab overhovedet hører inde i den kategori? Er Genmab blevet en så stor virksomhed, at risikoen er blevet lille og dermed også mulighederne for afkast? Det virker som om den eneste virkelige kurstrigger er, hvis Darzalex virker i solide,

    ]]>    https://dev.proinvestor.com/forum/post/10160677https://dev.proinvestor.com/forum/post/10160677Tue, 31 Oct 2017 19:07:47 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 18:04:08 GMT]]>enig JKY.

    ]]>    https://dev.proinvestor.com/forum/post/10160670https://dev.proinvestor.com/forum/post/10160670Tue, 31 Oct 2017 18:04:08 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 18:00:19 GMT]]>Så længe Novod ser kursfaldet som en købsmulighed er jeg helt rolig.

    ]]>    https://dev.proinvestor.com/forum/post/10160675https://dev.proinvestor.com/forum/post/10160675Tue, 31 Oct 2017 18:00:19 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 17:31:56 GMT]]>meanwhile this small study (36 patie
    nts for AML or MDS) now recruiting - https://clinicaltrials.gov/ct2/show/NCT03067571

    ]]>    https://dev.proinvestor.com/forum/post/10160674https://dev.proinvestor.com/forum/post/10160674Tue, 31 Oct 2017 17:31:56 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 17:29:35 GMT]]>thanks GB. a bit strange they changed just after Q3 numbers and now again. Maybe they did not like the "additional information" Genmab announced

    ]]>    https://dev.proinvestor.com/forum/post/10160676https://dev.proinvestor.com/forum/post/10160676Tue, 31 Oct 2017 17:29:35 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 17:12:40 GMT]]>GB, does SEB mention what their new sales estimate is?

    ]]>    https://dev.proinvestor.com/forum/post/10160673https://dev.proinvestor.com/forum/post/10160673Tue, 31 Oct 2017 17:12:40 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 17:07:12 GMT]]>EL - SEB lowered their sales estimat for Darzalex

    ]]>    https://dev.proinvestor.com/forum/post/10160667https://dev.proinvestor.com/forum/post/10160667Tue, 31 Oct 2017 17:07:12 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 15:54:16 GMT]]>haha Solsen, ja det er vist som vinden blæser, hvilket vi fik rigeligt af i weekenden:-)

    ]]>    https://dev.proinvestor.com/forum/post/10160668https://dev.proinvestor.com/forum/post/10160668Tue, 31 Oct 2017 15:54:16 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 15:53:09 GMT]]>Justering til aktuel kurs kunne de måske begrunde det med 😉

    ]]>    https://dev.proinvestor.com/forum/post/10160666https://dev.proinvestor.com/forum/post/10160666Tue, 31 Oct 2017 15:53:09 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 15:29:36 GMT]]>I share Your point E L...???!!!! - Why

    ]]>    https://dev.proinvestor.com/forum/post/10160672https://dev.proinvestor.com/forum/post/10160672Tue, 31 Oct 2017 15:29:36 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 15:21:26 GMT]]>based on what? they just moved it to 1430 less than 2 weeks ago? (and after JNJ earnings)

    ]]>    https://dev.proinvestor.com/forum/post/10160671https://dev.proinvestor.com/forum/post/10160671Tue, 31 Oct 2017 15:21:26 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 15:05:22 GMT]]>Hvor har du det fra GB?

    ]]>    https://dev.proinvestor.com/forum/post/10160663https://dev.proinvestor.com/forum/post/10160663Tue, 31 Oct 2017 15:05:22 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 15:04:07 GMT]]>JKY. - Jo du gjorde, men det var med små bogstaver.;-)

    ]]>    https://dev.proinvestor.com/forum/post/10160662https://dev.proinvestor.com/forum/post/10160662Tue, 31 Oct 2017 15:04:07 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 14:54:01 GMT]]>Ja ja...trods alt ikke under aktuel kurs -:)

    ]]>    https://dev.proinvestor.com/forum/post/10160661https://dev.proinvestor.com/forum/post/10160661Tue, 31 Oct 2017 14:54:01 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 14:49:50 GMT]]>hm tak GB

    ]]>    https://dev.proinvestor.com/forum/post/10160665https://dev.proinvestor.com/forum/post/10160665Tue, 31 Oct 2017 14:49:50 GMT    <![CDATA[Reply to Genmab — Oktober 2017 on Tue, 31 Oct 2017 14:48:27 GMT]]>SEB sænker målkurs på Genmab til 1280 fra 1430. SEB h
    ar stadig en hold anbefaling.

    ]]>    https://dev.proinvestor.com/forum/post/10160659https://dev.proinvestor.com/forum/post/10160659Tue, 31 Oct 2017 14:48:27 GMT